UNH - Medtronic Q3 in focus amid MedTech's post-COVID gains
2024-02-18 12:00:00 ET
More on Medtronic
- Medtronic Is A Healthy Portfolio Boost
- Medtronic: A Good Choice For Dividend Investors Seeking For Low Volatility
- Medtronic: Hugo's Global Rollout Is Positive; GLP-1 Is Negative
- Anti-obesity meds can expand the market for weight loss surgery: Bernstein
- Medtronic on track to record its seventh straight session in green